medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2015, Number 2

Next >>

Rev Invest Clin 2015; 67 (2)

Glycated Hemoglobin, Fasting, Two-hour Post-challenge and Postprandial Glycemia in the Diagnosis and Treatment of Diabetes Mellitus: Are We Giving Them the Right Interpretation and Use?

Gómez-Pérez FJ

Language: English
References: 30
Page: 76-79
PDF size: 166.03 Kb.


ABSTRACT

This brief review is aimed to point out the importance of considering glycated hemoglobin, fasting blood glucose, post-glucose-load glycemia, and postprandial glycemia into an evolutive and dynamic criteria that may grant a better concept and understanding of the diagnostic and therapeutic status of individual patients with type-2 diabetes mellitus.


REFERENCES

  1. Boshell BR, Gómez-Perez FJ. Diabetes Mellitus In: Conn HF, Conn RB, eds. Current Diagnosis. Philadelphia, London: WB Saunders, 1974:681.

  2. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin dependent diabetes mellitus. Diabetes control and Complications Trial. N Engl J Med. 1993;329:978-86.

  3. UK Prospective Diabetes Study Group intensive blood-glucose control. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-97.

  4. Consensus statement on the world-wide standardization of the hemoglobin A1c measurement: the America Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine and the International Diabetes Federation. Diabetes Care. 2007;30;2399-400.

  5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014:37(Suppl 1):S81-90.

  6. Home PD. Contributions of basal and postprandial hyperglycaemia to micro and macrovascular complications in people with type 2 diabetes. Curr Med Res Opin. 2005;21:989-98.

  7. The DECODE Study group, on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet. 1999;354:617-21.

  8. Nathan DM, McGee P, Steffes MW, Lachin JM; The DCCT/EDIC Research Group. Relationship of glycated albumin to blood glucose and Hba1c values and to retinopathy, nephropathy and cardiovascular outcomes in the DCCT/EDIC study. Diabetes. 2014;63:282-90.

  9. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-34.

  10. Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarenga JC, Perez- Jauregui J, Guillen-Pineda L, Rull JA. Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care. 1998;21:1886-8.

  11. Harris R, Donahue K, Rathore SS, Frame P, Woolf SH, Lohr KN. Screening adults for type 2 diabetes: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138:215-29.

  12. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2015;38(Suppl 1):S1-94.

  13. Goldstein DE, Little R, Lorenz RA, et al. Tests of glycaemia in diabetes. Diabetes Care. 2004;27:1771-3.

  14. The expert committee on the diagnosis and Classification of Diabetes Mellitus. Report of the Expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-97.

  15. van Leiden HA, Dekker JM, Moll AC. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn Study. Arch Ophtalmol. 2003;121:245-51.

  16. Tapp RJ, Tikellis G, Wong TY, Harper C, Zimmet PZ, Shaw JE. Longitudinal association of glucose metabolism with retinopathy. Diabetes Care. 2008;31:1349-54.

  17. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of Hba1c in predicting diabetes risk. J Gen Intern Med. 2004;19:1175-80.

  18. Ackerman RT, Chen YJ, Williamson DF, Gregg EW. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1C. National Health and Examination Survey 2005-2006. Am J Prev Med. 2011;40:11-17.

  19. Bonora E, Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care. 2011;34:S184-90.

  20. Gomez-Perez FJ, Aguilar-Salinas C, Almeda Valdes P, Cuevas- Ramos D, Lerman-Garber I, Rull JA. Hba1c for the diagnosis of diabetes mellitus in a developing country. A position article. Arch Med Res. 2010;41:302-8.

  21. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-34.

  22. Littke RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE. The National Glycohemoglobin standardization program: a five year progress report. Clin Chem. 2001:47:1985-92.

  23. Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM. The biosynthesis of human hemoglobin A1C. Slow glycosylation of hemoglobin in vivo. J Clin Invest. 1976;57:1652-9.

  24. Tahara Y, Shima K. The response of GHb to stepwise plasma glucose change overtime in diabetic patients, Diabetes Care. 1993;16:1313-14.

  25. van Riet E, Alssema M, Kijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM. Relationship between A1C and glucose levels in the general Dutch population. The new Hoorn Study. Diabetes Care. 2010;33:61-6.

  26. Cavagnolli G, Comerlato J, Renz PB, Goss JL, Camargo JL. HbA(1c) measurement for the diagnosis of diabetes: is it enough? Diabet Med. 2010;28:31-5.

  27. Nathan DM, McGee P, Steffes MW, Lachin JM; DCCT/EDIC Research Group. Relationship of glycated albumin to blood glucose and Hba1c values and to retinopathy, nephropathy and cardiovascular outcomes in the DCCT/EDIC study. Diabetes. 2014;63:282-90.

  28. Bonora E, Calcaterra F, Lombardi S, et al. Plasma glucose levels throughout the day and HbA1c, interrelationships in type 2 diabetes. Diabetes Care. 2001;24:2023-9.

  29. Mostafa SA, Davies MJ, Webb D, et al. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting type 2 diabetes mellitus. Diabet Med. 2010;27:762-9.

  30. Nathan DM, Kuenen J, Borg R, Schoenfeld D, Heine RJ. For the A1c-Derived Average Glucose (ADAG) Study Group. Translating the A1c assay into estimated average glucose values. Diabetes Care. 2008;31:1473-8.




2020     |     www.medigraphic.com